Reactivity of anti-histone antibodies induced by procainamide and hydralazine.
D000328:Adult; D000368:Aged; D000818:Animals; D000974:Antibodies, Antinuclear / Q000032:analysis; D000918:Antibody Specificity; D001323:Autoantibodies / Q000032:analysis / Q000096:biosynthesis*; D003240:Connective Tissue Diseases / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006657:Histones / Q000276:immunology*; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology*; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000145:classification; D007592:Joint Diseases / Q000188:drug therapy / Q000276:immunology; D008297:Male; D051379:Mice; D008875:Middle Aged; D011342:Procainamide / Q000494:pharmacology* / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D006657:Histones; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D006830:Hydralazine; D011342:Procainamide